Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: TechNavio | PRODUCT CODE: 1756590

Cover Image

PUBLISHER: TechNavio | PRODUCT CODE: 1756590

Global Mono Vaccine Market 2025-2029

PUBLISHED:
PAGES: 209 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 2500
PDF (Enterprise License)
USD 4000

Add to Cart

The mono vaccine market is forecasted to grow by USD 2,665 mn during 2024-2029, accelerating at a CAGR of 4.6% during the forecast period. The report on the mono vaccine market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increase in pediatric population, initiatives from government agencies, and recent drug approvals and product innovations.

Market Scope
Base Year2025
End Year2029
Series Year2025-2029
Growth MomentumAccelerate
YOY 20254.4%
CAGR4.6%
Incremental Value$2,665 mn

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's mono vaccine market is segmented as below:

By Type

    • Meningococcal vaccine
    • Japanese encephalitis vaccine
    • Hepatitis vaccine
    • Yellow fever vaccine
    • Others

By Application

    • Adults
    • Children

By End-user

    • Hospitals
    • Specialty clinics
    • Research institutions
    • Pharmaceutical companies

By Geographical Landscape

    • North America
    • Europe
    • Asia
    • Rest of World (ROW)

This study identifies the increase in mergers and acquisitions as one of the prime reasons driving the mono vaccine market growth during the next few years. Also, advancement in vaccine delivery system and increasing research on combination therapies will lead to sizable demand in the market.

The report on the mono vaccine market covers the following areas:

    • Mono Vaccine Market sizing
    • Mono Vaccine Market forecast
    • Mono Vaccine Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading mono vaccine market vendors that include AstraZeneca Plc, Aurobindo Pharma Ltd., Bavarian Nordic AS, China National Pharmaceutical Group Corp., Dynavax Technologies Corp., GlaxoSmithKline Plc, Johnson and Johnson Services Inc., Merck and Co. Inc., Moderna Inc., Pfizer Inc., Sanofi SA, Serum Institute of India Pvt. Ltd., Shenzhen Kangtai Biological Products Co. Ltd., Valneva SE, VBI Vaccines Inc., and Zydus Lifesciences Ltd.. Also, the mono vaccine market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Product Code: IRTNTR74519

Table of Contents

1 Executive Summary

  • 1.1 Market overview
    • Executive Summary - Chart on Market Overview
    • Executive Summary - Data Table on Market Overview
    • Executive Summary - Chart on Global Market Characteristics
    • Executive Summary - Chart on Market By Geographical Landscape
    • Executive Summary - Chart on Market Segmentation by Type
    • Executive Summary - Chart on Market Segmentation by Application
    • Executive Summary - Chart on Market Segmentation by End-user
    • Executive Summary - Chart on Incremental Growth
    • Executive Summary - Data Table on Incremental Growth
    • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

  • 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • 2.2 Criticality of inputs and Factors of differentiation
    • Overview on criticality of inputs and factors of differentiation
  • 2.3 Factors of disruption
    • Overview on factors of disruption
  • 2.4 Impact of drivers and challenges
    • Impact of drivers and challenges in 2024 and 2029

3 Market Landscape

  • 3.1 Market ecosystem
    • Parent Market
    • Data Table on - Parent Market
  • 3.2 Market characteristics
    • Market characteristics analysis
  • 3.3 Value chain analysis
    • Value chain analysis

4 Market Sizing

  • 4.1 Market definition
    • Offerings of companies included in the market definition
  • 4.2 Market segment analysis
    • Market segments
  • 4.3 Market size 2024
  • 4.4 Market outlook: Forecast for 2024-2029
    • Chart on Global - Market size and forecast 2024-2029 ($ million)
    • Data Table on Global - Market size and forecast 2024-2029 ($ million)
    • Chart on Global Market: Year-over-year growth 2024-2029 (%)
    • Data Table on Global Market: Year-over-year growth 2024-2029 (%)

5 Historic Market Size

  • 5.1 Global Mono Vaccine Market 2019 - 2023
    • Historic Market Size - Data Table on Global Mono Vaccine Market 2019 - 2023 ($ million)
  • 5.2 Type segment analysis 2019 - 2023
    • Historic Market Size - Type Segment 2019 - 2023 ($ million)
  • 5.3 Application segment analysis 2019 - 2023
    • Historic Market Size - Application Segment 2019 - 2023 ($ million)
  • 5.4 End-user segment analysis 2019 - 2023
    • Historic Market Size - End-user Segment 2019 - 2023 ($ million)
  • 5.5 Geography segment analysis 2019 - 2023
    • Historic Market Size - Geography Segment 2019 - 2023 ($ million)
  • 5.6 Country segment analysis 2019 - 2023
    • Historic Market Size - Country Segment 2019 - 2023 ($ million)

6 Qualitative Analysis

  • 6.1 The impact of AI in the global mono vaccine market

7 Five Forces Analysis

  • 7.1 Five forces summary
    • Five forces analysis - Comparison between 2024 and 2029
  • 7.2 Bargaining power of buyers
    • Bargaining power of buyers - Impact of key factors 2024 and 2029
  • 7.3 Bargaining power of suppliers
    • Bargaining power of suppliers - Impact of key factors in 2024 and 2029
  • 7.4 Threat of new entrants
    • Threat of new entrants - Impact of key factors in 2024 and 2029
  • 7.5 Threat of substitutes
    • Threat of substitutes - Impact of key factors in 2024 and 2029
  • 7.6 Threat of rivalry
    • Threat of rivalry - Impact of key factors in 2024 and 2029
  • 7.7 Market condition
    • Chart on Market condition - Five forces 2024 and 2029

8 Market Segmentation by Type

  • 8.1 Market segments
    • Chart on Type - Market share 2024-2029 (%)
    • Data Table on Type - Market share 2024-2029 (%)
  • 8.2 Comparison by Type
    • Chart on Comparison by Type
    • Data Table on Comparison by Type
  • 8.3 Meningococcal vaccine - Market size and forecast 2024-2029
    • Chart on Meningococcal vaccine - Market size and forecast 2024-2029 ($ million)
    • Data Table on Meningococcal vaccine - Market size and forecast 2024-2029 ($ million)
    • Chart on Meningococcal vaccine - Year-over-year growth 2024-2029 (%)
    • Data Table on Meningococcal vaccine - Year-over-year growth 2024-2029 (%)
  • 8.4 Japanese encephalitis vaccine - Market size and forecast 2024-2029
    • Chart on Japanese encephalitis vaccine - Market size and forecast 2024-2029 ($ million)
    • Data Table on Japanese encephalitis vaccine - Market size and forecast 2024-2029 ($ million)
    • Chart on Japanese encephalitis vaccine - Year-over-year growth 2024-2029 (%)
    • Data Table on Japanese encephalitis vaccine - Year-over-year growth 2024-2029 (%)
  • 8.5 Hepatitis vaccine - Market size and forecast 2024-2029
    • Chart on Hepatitis vaccine - Market size and forecast 2024-2029 ($ million)
    • Data Table on Hepatitis vaccine - Market size and forecast 2024-2029 ($ million)
    • Chart on Hepatitis vaccine - Year-over-year growth 2024-2029 (%)
    • Data Table on Hepatitis vaccine - Year-over-year growth 2024-2029 (%)
  • 8.6 Yellow fever vaccine - Market size and forecast 2024-2029
    • Chart on Yellow fever vaccine - Market size and forecast 2024-2029 ($ million)
    • Data Table on Yellow fever vaccine - Market size and forecast 2024-2029 ($ million)
    • Chart on Yellow fever vaccine - Year-over-year growth 2024-2029 (%)
    • Data Table on Yellow fever vaccine - Year-over-year growth 2024-2029 (%)
  • 8.7 Others - Market size and forecast 2024-2029
    • Chart on Others - Market size and forecast 2024-2029 ($ million)
    • Data Table on Others - Market size and forecast 2024-2029 ($ million)
    • Chart on Others - Year-over-year growth 2024-2029 (%)
    • Data Table on Others - Year-over-year growth 2024-2029 (%)
  • 8.8 Market opportunity by Type
    • Market opportunity by Type ($ million)
    • Data Table on Market opportunity by Type ($ million)

9 Market Segmentation by Application

  • 9.1 Market segments
    • Chart on Application - Market share 2024-2029 (%)
    • Data Table on Application - Market share 2024-2029 (%)
  • 9.2 Comparison by Application
    • Chart on Comparison by Application
    • Data Table on Comparison by Application
  • 9.3 Adults - Market size and forecast 2024-2029
    • Chart on Adults - Market size and forecast 2024-2029 ($ million)
    • Data Table on Adults - Market size and forecast 2024-2029 ($ million)
    • Chart on Adults - Year-over-year growth 2024-2029 (%)
    • Data Table on Adults - Year-over-year growth 2024-2029 (%)
  • 9.4 Children - Market size and forecast 2024-2029
    • Chart on Children - Market size and forecast 2024-2029 ($ million)
    • Data Table on Children - Market size and forecast 2024-2029 ($ million)
    • Chart on Children - Year-over-year growth 2024-2029 (%)
    • Data Table on Children - Year-over-year growth 2024-2029 (%)
  • 9.5 Market opportunity by Application
    • Market opportunity by Application ($ million)
    • Data Table on Market opportunity by Application ($ million)

10 Market Segmentation by End-user

  • 10.1 Market segments
    • Chart on End-user - Market share 2024-2029 (%)
    • Data Table on End-user - Market share 2024-2029 (%)
  • 10.2 Comparison by End-user
    • Chart on Comparison by End-user
    • Data Table on Comparison by End-user
  • 10.3 Hospitals - Market size and forecast 2024-2029
    • Chart on Hospitals - Market size and forecast 2024-2029 ($ million)
    • Data Table on Hospitals - Market size and forecast 2024-2029 ($ million)
    • Chart on Hospitals - Year-over-year growth 2024-2029 (%)
    • Data Table on Hospitals - Year-over-year growth 2024-2029 (%)
  • 10.4 Specialty clinics - Market size and forecast 2024-2029
    • Chart on Specialty clinics - Market size and forecast 2024-2029 ($ million)
    • Data Table on Specialty clinics - Market size and forecast 2024-2029 ($ million)
    • Chart on Specialty clinics - Year-over-year growth 2024-2029 (%)
    • Data Table on Specialty clinics - Year-over-year growth 2024-2029 (%)
  • 10.5 Research institutions - Market size and forecast 2024-2029
    • Chart on Research institutions - Market size and forecast 2024-2029 ($ million)
    • Data Table on Research institutions - Market size and forecast 2024-2029 ($ million)
    • Chart on Research institutions - Year-over-year growth 2024-2029 (%)
    • Data Table on Research institutions - Year-over-year growth 2024-2029 (%)
  • 10.6 Pharmaceutical companies - Market size and forecast 2024-2029
    • Chart on Pharmaceutical companies - Market size and forecast 2024-2029 ($ million)
    • Data Table on Pharmaceutical companies - Market size and forecast 2024-2029 ($ million)
    • Chart on Pharmaceutical companies - Year-over-year growth 2024-2029 (%)
    • Data Table on Pharmaceutical companies - Year-over-year growth 2024-2029 (%)
  • 10.7 Market opportunity by End-user
    • Market opportunity by End-user ($ million)
    • Data Table on Market opportunity by End-user ($ million)

11 Customer Landscape

  • 11.1 Customer landscape overview
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

  • 12.1 Geographic segmentation
    • Chart on Market share By Geographical Landscape 2024-2029 (%)
    • Data Table on Market share By Geographical Landscape 2024-2029 (%)
  • 12.2 Geographic comparison
    • Chart on Geographic comparison
    • Data Table on Geographic comparison
  • 12.3 North America - Market size and forecast 2024-2029
    • Chart on North America - Market size and forecast 2024-2029 ($ million)
    • Data Table on North America - Market size and forecast 2024-2029 ($ million)
    • Chart on North America - Year-over-year growth 2024-2029 (%)
    • Data Table on North America - Year-over-year growth 2024-2029 (%)
  • 12.4 Europe - Market size and forecast 2024-2029
    • Chart on Europe - Market size and forecast 2024-2029 ($ million)
    • Data Table on Europe - Market size and forecast 2024-2029 ($ million)
    • Chart on Europe - Year-over-year growth 2024-2029 (%)
    • Data Table on Europe - Year-over-year growth 2024-2029 (%)
  • 12.5 Asia - Market size and forecast 2024-2029
    • Chart on Asia - Market size and forecast 2024-2029 ($ million)
    • Data Table on Asia - Market size and forecast 2024-2029 ($ million)
    • Chart on Asia - Year-over-year growth 2024-2029 (%)
    • Data Table on Asia - Year-over-year growth 2024-2029 (%)
  • 12.6 Rest of World (ROW) - Market size and forecast 2024-2029
    • Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
    • Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
    • Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
    • Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
  • 12.7 US - Market size and forecast 2024-2029
    • Chart on US - Market size and forecast 2024-2029 ($ million)
    • Data Table on US - Market size and forecast 2024-2029 ($ million)
    • Chart on US - Year-over-year growth 2024-2029 (%)
    • Data Table on US - Year-over-year growth 2024-2029 (%)
  • 12.8 Germany - Market size and forecast 2024-2029
    • Chart on Germany - Market size and forecast 2024-2029 ($ million)
    • Data Table on Germany - Market size and forecast 2024-2029 ($ million)
    • Chart on Germany - Year-over-year growth 2024-2029 (%)
    • Data Table on Germany - Year-over-year growth 2024-2029 (%)
  • 12.9 UK - Market size and forecast 2024-2029
    • Chart on UK - Market size and forecast 2024-2029 ($ million)
    • Data Table on UK - Market size and forecast 2024-2029 ($ million)
    • Chart on UK - Year-over-year growth 2024-2029 (%)
    • Data Table on UK - Year-over-year growth 2024-2029 (%)
  • 12.10 Canada - Market size and forecast 2024-2029
    • Chart on Canada - Market size and forecast 2024-2029 ($ million)
    • Data Table on Canada - Market size and forecast 2024-2029 ($ million)
    • Chart on Canada - Year-over-year growth 2024-2029 (%)
    • Data Table on Canada - Year-over-year growth 2024-2029 (%)
  • 12.11 France - Market size and forecast 2024-2029
    • Chart on France - Market size and forecast 2024-2029 ($ million)
    • Data Table on France - Market size and forecast 2024-2029 ($ million)
    • Chart on France - Year-over-year growth 2024-2029 (%)
    • Data Table on France - Year-over-year growth 2024-2029 (%)
  • 12.12 Italy - Market size and forecast 2024-2029
    • Chart on Italy - Market size and forecast 2024-2029 ($ million)
    • Data Table on Italy - Market size and forecast 2024-2029 ($ million)
    • Chart on Italy - Year-over-year growth 2024-2029 (%)
    • Data Table on Italy - Year-over-year growth 2024-2029 (%)
  • 12.13 China - Market size and forecast 2024-2029
    • Chart on China - Market size and forecast 2024-2029 ($ million)
    • Data Table on China - Market size and forecast 2024-2029 ($ million)
    • Chart on China - Year-over-year growth 2024-2029 (%)
    • Data Table on China - Year-over-year growth 2024-2029 (%)
  • 12.14 Spain - Market size and forecast 2024-2029
    • Chart on Spain - Market size and forecast 2024-2029 ($ million)
    • Data Table on Spain - Market size and forecast 2024-2029 ($ million)
    • Chart on Spain - Year-over-year growth 2024-2029 (%)
    • Data Table on Spain - Year-over-year growth 2024-2029 (%)
  • 12.15 Japan - Market size and forecast 2024-2029
    • Chart on Japan - Market size and forecast 2024-2029 ($ million)
    • Data Table on Japan - Market size and forecast 2024-2029 ($ million)
    • Chart on Japan - Year-over-year growth 2024-2029 (%)
    • Data Table on Japan - Year-over-year growth 2024-2029 (%)
  • 12.16 India - Market size and forecast 2024-2029
    • Chart on India - Market size and forecast 2024-2029 ($ million)
    • Data Table on India - Market size and forecast 2024-2029 ($ million)
    • Chart on India - Year-over-year growth 2024-2029 (%)
    • Data Table on India - Year-over-year growth 2024-2029 (%)
  • 12.17 Market opportunity By Geographical Landscape
    • Market opportunity By Geographical Landscape ($ million)
    • Data Tables on Market opportunity By Geographical Landscape ($ million)

13 Drivers, Challenges, and Opportunity/Restraints

  • 13.1 Market drivers
  • 13.2 Market challenges
  • 13.3 Impact of drivers and challenges
    • Impact of drivers and challenges in 2024 and 2029
  • 13.4 Market opportunities/restraints

14 Competitive Landscape

  • 14.1 Overview
  • 14.2 Competitive Landscape
    • Overview on criticality of inputs and factors of differentiation
  • 14.3 Landscape disruption
    • Overview on factors of disruption
  • 14.4 Industry risks
    • Impact of key risks on business

15 Competitive Analysis

  • 15.1 Companies profiled
    • Companies covered
  • 15.2 Company ranking index
    • Company ranking index
  • 15.3 Market positioning of companies
    • Matrix on companies position and classification
  • 15.4 AstraZeneca Plc
    • AstraZeneca Plc - Overview
    • AstraZeneca Plc - Product / Service
    • AstraZeneca Plc - Key news
    • AstraZeneca Plc - Key offerings
    • SWOT
  • 15.5 Bavarian Nordic AS
    • Bavarian Nordic AS - Overview
    • Bavarian Nordic AS - Product / Service
    • Bavarian Nordic AS - Key offerings
    • SWOT
  • 15.6 China National Pharmaceutical Group Corp.
    • China National Pharmaceutical Group Corp. - Overview
    • China National Pharmaceutical Group Corp. - Product / Service
    • China National Pharmaceutical Group Corp. - Key offerings
    • SWOT
  • 15.7 Dynavax Technologies Corp.
    • Dynavax Technologies Corp. - Overview
    • Dynavax Technologies Corp. - Product / Service
    • Dynavax Technologies Corp. - Key offerings
    • SWOT
  • 15.8 GlaxoSmithKline Plc
    • GlaxoSmithKline Plc - Overview
    • GlaxoSmithKline Plc - Business segments
    • GlaxoSmithKline Plc - Key news
    • GlaxoSmithKline Plc - Key offerings
    • GlaxoSmithKline Plc - Segment focus
    • SWOT
  • 15.9 Johnson and Johnson Services Inc.
    • Johnson and Johnson Services Inc. - Overview
    • Johnson and Johnson Services Inc. - Business segments
    • Johnson and Johnson Services Inc. - Key news
    • Johnson and Johnson Services Inc. - Key offerings
    • Johnson and Johnson Services Inc. - Segment focus
    • SWOT
  • 15.10 Merck and Co. Inc.
    • Merck and Co. Inc. - Overview
    • Merck and Co. Inc. - Business segments
    • Merck and Co. Inc. - Key news
    • Merck and Co. Inc. - Key offerings
    • Merck and Co. Inc. - Segment focus
    • SWOT
  • 15.11 Moderna Inc.
    • Moderna Inc. - Overview
    • Moderna Inc. - Product / Service
    • Moderna Inc. - Key offerings
    • SWOT
  • 15.12 Pfizer Inc.
    • Pfizer Inc. - Overview
    • Pfizer Inc. - Product / Service
    • Pfizer Inc. - Key news
    • Pfizer Inc. - Key offerings
    • SWOT
  • 15.13 Sanofi SA
    • Sanofi SA - Overview
    • Sanofi SA - Business segments
    • Sanofi SA - Key news
    • Sanofi SA - Key offerings
    • Sanofi SA - Segment focus
    • SWOT
  • 15.14 Serum Institute of India Pvt. Ltd.
    • Serum Institute of India Pvt. Ltd. - Overview
    • Serum Institute of India Pvt. Ltd. - Product / Service
    • Serum Institute of India Pvt. Ltd. - Key offerings
    • SWOT
  • 15.15 Shenzhen Kangtai Biological Products Co. Ltd.
    • Shenzhen Kangtai Biological Products Co. Ltd. - Overview
    • Shenzhen Kangtai Biological Products Co. Ltd. - Product / Service
    • Shenzhen Kangtai Biological Products Co. Ltd. - Key offerings
    • SWOT
  • 15.16 Valneva SE
    • Valneva SE - Overview
    • Valneva SE - Business segments
    • Valneva SE - Key offerings
    • Valneva SE - Segment focus
    • SWOT
  • 15.17 VBI Vaccines Inc.
    • VBI Vaccines Inc. - Overview
    • VBI Vaccines Inc. - Product / Service
    • VBI Vaccines Inc. - Key offerings
    • SWOT
  • 15.18 Zydus Lifesciences Ltd.
    • Zydus Lifesciences Ltd. - Overview
    • Zydus Lifesciences Ltd. - Business segments
    • Zydus Lifesciences Ltd. - Key news
    • Zydus Lifesciences Ltd. - Key offerings
    • Zydus Lifesciences Ltd. - Segment focus
    • SWOT

16 Appendix

  • 16.1 Scope of the report
  • 16.2 Inclusions and exclusions checklist
    • Inclusions checklist
    • Exclusions checklist
  • 16.3 Currency conversion rates for US$
    • Currency conversion rates for US$
  • 16.4 Research methodology
    • Research methodology
  • 16.5 Data procurement
    • Information sources
  • 16.6 Data validation
    • Data validation
  • 16.7 Validation techniques employed for market sizing
    • Validation techniques employed for market sizing
  • 16.8 Data synthesis
    • Data synthesis
  • 16.9 360 degree market analysis
    • 360 degree market analysis
  • 16.10 List of abbreviations
    • List of abbreviations
Product Code: IRTNTR74519

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibits5: Executive Summary - Chart on Market Segmentation by Type
  • Exhibits6: Executive Summary - Chart on Market Segmentation by Application
  • Exhibits7: Executive Summary - Chart on Market Segmentation by End-user
  • Exhibits8: Executive Summary - Chart on Incremental Growth
  • Exhibits9: Executive Summary - Data Table on Incremental Growth
  • Exhibits10: Executive Summary - Chart on Company Market Positioning
  • Exhibits11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits12: Overview on criticality of inputs and factors of differentiation
  • Exhibits13: Overview on factors of disruption
  • Exhibits14: Impact of drivers and challenges in 2024 and 2029
  • Exhibits15: Parent Market
  • Exhibits16: Data Table on - Parent Market
  • Exhibits17: Market characteristics analysis
  • Exhibits18: Value chain analysis
  • Exhibits19: Offerings of companies included in the market definition
  • Exhibits20: Market segments
  • Exhibits21: Chart on Global - Market size and forecast 2024-2029 ($ million)
  • Exhibits22: Data Table on Global - Market size and forecast 2024-2029 ($ million)
  • Exhibits23: Chart on Global Market: Year-over-year growth 2024-2029 (%)
  • Exhibits24: Data Table on Global Market: Year-over-year growth 2024-2029 (%)
  • Exhibits25: Historic Market Size - Data Table on Global Mono Vaccine Market 2019 - 2023 ($ million)
  • Exhibits26: Historic Market Size - Type Segment 2019 - 2023 ($ million)
  • Exhibits27: Historic Market Size - Application Segment 2019 - 2023 ($ million)
  • Exhibits28: Historic Market Size - End-user Segment 2019 - 2023 ($ million)
  • Exhibits29: Historic Market Size - Geography Segment 2019 - 2023 ($ million)
  • Exhibits30: Historic Market Size - Country Segment 2019 - 2023 ($ million)
  • Exhibits31: Five forces analysis - Comparison between 2024 and 2029
  • Exhibits32: Bargaining power of buyers - Impact of key factors 2024 and 2029
  • Exhibits33: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
  • Exhibits34: Threat of new entrants - Impact of key factors in 2024 and 2029
  • Exhibits35: Threat of substitutes - Impact of key factors in 2024 and 2029
  • Exhibits36: Threat of rivalry - Impact of key factors in 2024 and 2029
  • Exhibits37: Chart on Market condition - Five forces 2024 and 2029
  • Exhibits38: Chart on Type - Market share 2024-2029 (%)
  • Exhibits39: Data Table on Type - Market share 2024-2029 (%)
  • Exhibits40: Chart on Comparison by Type
  • Exhibits41: Data Table on Comparison by Type
  • Exhibits42: Chart on Meningococcal vaccine - Market size and forecast 2024-2029 ($ million)
  • Exhibits43: Data Table on Meningococcal vaccine - Market size and forecast 2024-2029 ($ million)
  • Exhibits44: Chart on Meningococcal vaccine - Year-over-year growth 2024-2029 (%)
  • Exhibits45: Data Table on Meningococcal vaccine - Year-over-year growth 2024-2029 (%)
  • Exhibits46: Chart on Japanese encephalitis vaccine - Market size and forecast 2024-2029 ($ million)
  • Exhibits47: Data Table on Japanese encephalitis vaccine - Market size and forecast 2024-2029 ($ million)
  • Exhibits48: Chart on Japanese encephalitis vaccine - Year-over-year growth 2024-2029 (%)
  • Exhibits49: Data Table on Japanese encephalitis vaccine - Year-over-year growth 2024-2029 (%)
  • Exhibits50: Chart on Hepatitis vaccine - Market size and forecast 2024-2029 ($ million)
  • Exhibits51: Data Table on Hepatitis vaccine - Market size and forecast 2024-2029 ($ million)
  • Exhibits52: Chart on Hepatitis vaccine - Year-over-year growth 2024-2029 (%)
  • Exhibits53: Data Table on Hepatitis vaccine - Year-over-year growth 2024-2029 (%)
  • Exhibits54: Chart on Yellow fever vaccine - Market size and forecast 2024-2029 ($ million)
  • Exhibits55: Data Table on Yellow fever vaccine - Market size and forecast 2024-2029 ($ million)
  • Exhibits56: Chart on Yellow fever vaccine - Year-over-year growth 2024-2029 (%)
  • Exhibits57: Data Table on Yellow fever vaccine - Year-over-year growth 2024-2029 (%)
  • Exhibits58: Chart on Others - Market size and forecast 2024-2029 ($ million)
  • Exhibits59: Data Table on Others - Market size and forecast 2024-2029 ($ million)
  • Exhibits60: Chart on Others - Year-over-year growth 2024-2029 (%)
  • Exhibits61: Data Table on Others - Year-over-year growth 2024-2029 (%)
  • Exhibits62: Market opportunity by Type ($ million)
  • Exhibits63: Data Table on Market opportunity by Type ($ million)
  • Exhibits64: Chart on Application - Market share 2024-2029 (%)
  • Exhibits65: Data Table on Application - Market share 2024-2029 (%)
  • Exhibits66: Chart on Comparison by Application
  • Exhibits67: Data Table on Comparison by Application
  • Exhibits68: Chart on Adults - Market size and forecast 2024-2029 ($ million)
  • Exhibits69: Data Table on Adults - Market size and forecast 2024-2029 ($ million)
  • Exhibits70: Chart on Adults - Year-over-year growth 2024-2029 (%)
  • Exhibits71: Data Table on Adults - Year-over-year growth 2024-2029 (%)
  • Exhibits72: Chart on Children - Market size and forecast 2024-2029 ($ million)
  • Exhibits73: Data Table on Children - Market size and forecast 2024-2029 ($ million)
  • Exhibits74: Chart on Children - Year-over-year growth 2024-2029 (%)
  • Exhibits75: Data Table on Children - Year-over-year growth 2024-2029 (%)
  • Exhibits76: Market opportunity by Application ($ million)
  • Exhibits77: Data Table on Market opportunity by Application ($ million)
  • Exhibits78: Chart on End-user - Market share 2024-2029 (%)
  • Exhibits79: Data Table on End-user - Market share 2024-2029 (%)
  • Exhibits80: Chart on Comparison by End-user
  • Exhibits81: Data Table on Comparison by End-user
  • Exhibits82: Chart on Hospitals - Market size and forecast 2024-2029 ($ million)
  • Exhibits83: Data Table on Hospitals - Market size and forecast 2024-2029 ($ million)
  • Exhibits84: Chart on Hospitals - Year-over-year growth 2024-2029 (%)
  • Exhibits85: Data Table on Hospitals - Year-over-year growth 2024-2029 (%)
  • Exhibits86: Chart on Specialty clinics - Market size and forecast 2024-2029 ($ million)
  • Exhibits87: Data Table on Specialty clinics - Market size and forecast 2024-2029 ($ million)
  • Exhibits88: Chart on Specialty clinics - Year-over-year growth 2024-2029 (%)
  • Exhibits89: Data Table on Specialty clinics - Year-over-year growth 2024-2029 (%)
  • Exhibits90: Chart on Research institutions - Market size and forecast 2024-2029 ($ million)
  • Exhibits91: Data Table on Research institutions - Market size and forecast 2024-2029 ($ million)
  • Exhibits92: Chart on Research institutions - Year-over-year growth 2024-2029 (%)
  • Exhibits93: Data Table on Research institutions - Year-over-year growth 2024-2029 (%)
  • Exhibits94: Chart on Pharmaceutical companies - Market size and forecast 2024-2029 ($ million)
  • Exhibits95: Data Table on Pharmaceutical companies - Market size and forecast 2024-2029 ($ million)
  • Exhibits96: Chart on Pharmaceutical companies - Year-over-year growth 2024-2029 (%)
  • Exhibits97: Data Table on Pharmaceutical companies - Year-over-year growth 2024-2029 (%)
  • Exhibits98: Market opportunity by End-user ($ million)
  • Exhibits99: Data Table on Market opportunity by End-user ($ million)
  • Exhibits100: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits101: Chart on Market share By Geographical Landscape 2024-2029 (%)
  • Exhibits102: Data Table on Market share By Geographical Landscape 2024-2029 (%)
  • Exhibits103: Chart on Geographic comparison
  • Exhibits104: Data Table on Geographic comparison
  • Exhibits105: Chart on North America - Market size and forecast 2024-2029 ($ million)
  • Exhibits106: Data Table on North America - Market size and forecast 2024-2029 ($ million)
  • Exhibits107: Chart on North America - Year-over-year growth 2024-2029 (%)
  • Exhibits108: Data Table on North America - Year-over-year growth 2024-2029 (%)
  • Exhibits109: Chart on Europe - Market size and forecast 2024-2029 ($ million)
  • Exhibits110: Data Table on Europe - Market size and forecast 2024-2029 ($ million)
  • Exhibits111: Chart on Europe - Year-over-year growth 2024-2029 (%)
  • Exhibits112: Data Table on Europe - Year-over-year growth 2024-2029 (%)
  • Exhibits113: Chart on Asia - Market size and forecast 2024-2029 ($ million)
  • Exhibits114: Data Table on Asia - Market size and forecast 2024-2029 ($ million)
  • Exhibits115: Chart on Asia - Year-over-year growth 2024-2029 (%)
  • Exhibits116: Data Table on Asia - Year-over-year growth 2024-2029 (%)
  • Exhibits117: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
  • Exhibits118: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
  • Exhibits119: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
  • Exhibits120: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
  • Exhibits121: Chart on US - Market size and forecast 2024-2029 ($ million)
  • Exhibits122: Data Table on US - Market size and forecast 2024-2029 ($ million)
  • Exhibits123: Chart on US - Year-over-year growth 2024-2029 (%)
  • Exhibits124: Data Table on US - Year-over-year growth 2024-2029 (%)
  • Exhibits125: Chart on Germany - Market size and forecast 2024-2029 ($ million)
  • Exhibits126: Data Table on Germany - Market size and forecast 2024-2029 ($ million)
  • Exhibits127: Chart on Germany - Year-over-year growth 2024-2029 (%)
  • Exhibits128: Data Table on Germany - Year-over-year growth 2024-2029 (%)
  • Exhibits129: Chart on UK - Market size and forecast 2024-2029 ($ million)
  • Exhibits130: Data Table on UK - Market size and forecast 2024-2029 ($ million)
  • Exhibits131: Chart on UK - Year-over-year growth 2024-2029 (%)
  • Exhibits132: Data Table on UK - Year-over-year growth 2024-2029 (%)
  • Exhibits133: Chart on Canada - Market size and forecast 2024-2029 ($ million)
  • Exhibits134: Data Table on Canada - Market size and forecast 2024-2029 ($ million)
  • Exhibits135: Chart on Canada - Year-over-year growth 2024-2029 (%)
  • Exhibits136: Data Table on Canada - Year-over-year growth 2024-2029 (%)
  • Exhibits137: Chart on France - Market size and forecast 2024-2029 ($ million)
  • Exhibits138: Data Table on France - Market size and forecast 2024-2029 ($ million)
  • Exhibits139: Chart on France - Year-over-year growth 2024-2029 (%)
  • Exhibits140: Data Table on France - Year-over-year growth 2024-2029 (%)
  • Exhibits141: Chart on Italy - Market size and forecast 2024-2029 ($ million)
  • Exhibits142: Data Table on Italy - Market size and forecast 2024-2029 ($ million)
  • Exhibits143: Chart on Italy - Year-over-year growth 2024-2029 (%)
  • Exhibits144: Data Table on Italy - Year-over-year growth 2024-2029 (%)
  • Exhibits145: Chart on China - Market size and forecast 2024-2029 ($ million)
  • Exhibits146: Data Table on China - Market size and forecast 2024-2029 ($ million)
  • Exhibits147: Chart on China - Year-over-year growth 2024-2029 (%)
  • Exhibits148: Data Table on China - Year-over-year growth 2024-2029 (%)
  • Exhibits149: Chart on Spain - Market size and forecast 2024-2029 ($ million)
  • Exhibits150: Data Table on Spain - Market size and forecast 2024-2029 ($ million)
  • Exhibits151: Chart on Spain - Year-over-year growth 2024-2029 (%)
  • Exhibits152: Data Table on Spain - Year-over-year growth 2024-2029 (%)
  • Exhibits153: Chart on Japan - Market size and forecast 2024-2029 ($ million)
  • Exhibits154: Data Table on Japan - Market size and forecast 2024-2029 ($ million)
  • Exhibits155: Chart on Japan - Year-over-year growth 2024-2029 (%)
  • Exhibits156: Data Table on Japan - Year-over-year growth 2024-2029 (%)
  • Exhibits157: Chart on India - Market size and forecast 2024-2029 ($ million)
  • Exhibits158: Data Table on India - Market size and forecast 2024-2029 ($ million)
  • Exhibits159: Chart on India - Year-over-year growth 2024-2029 (%)
  • Exhibits160: Data Table on India - Year-over-year growth 2024-2029 (%)
  • Exhibits161: Market opportunity By Geographical Landscape ($ million)
  • Exhibits162: Data Tables on Market opportunity By Geographical Landscape ($ million)
  • Exhibits163: Impact of drivers and challenges in 2024 and 2029
  • Exhibits164: Overview on criticality of inputs and factors of differentiation
  • Exhibits165: Overview on factors of disruption
  • Exhibits166: Impact of key risks on business
  • Exhibits167: Companies covered
  • Exhibits168: Company ranking index
  • Exhibits169: Matrix on companies position and classification
  • Exhibits170: AstraZeneca Plc - Overview
  • Exhibits171: AstraZeneca Plc - Product / Service
  • Exhibits172: AstraZeneca Plc - Key news
  • Exhibits173: AstraZeneca Plc - Key offerings
  • Exhibits174: SWOT
  • Exhibits175: Bavarian Nordic AS - Overview
  • Exhibits176: Bavarian Nordic AS - Product / Service
  • Exhibits177: Bavarian Nordic AS - Key offerings
  • Exhibits178: SWOT
  • Exhibits179: China National Pharmaceutical Group Corp. - Overview
  • Exhibits180: China National Pharmaceutical Group Corp. - Product / Service
  • Exhibits181: China National Pharmaceutical Group Corp. - Key offerings
  • Exhibits182: SWOT
  • Exhibits183: Dynavax Technologies Corp. - Overview
  • Exhibits184: Dynavax Technologies Corp. - Product / Service
  • Exhibits185: Dynavax Technologies Corp. - Key offerings
  • Exhibits186: SWOT
  • Exhibits187: GlaxoSmithKline Plc - Overview
  • Exhibits188: GlaxoSmithKline Plc - Business segments
  • Exhibits189: GlaxoSmithKline Plc - Key news
  • Exhibits190: GlaxoSmithKline Plc - Key offerings
  • Exhibits191: GlaxoSmithKline Plc - Segment focus
  • Exhibits192: SWOT
  • Exhibits193: Johnson and Johnson Services Inc. - Overview
  • Exhibits194: Johnson and Johnson Services Inc. - Business segments
  • Exhibits195: Johnson and Johnson Services Inc. - Key news
  • Exhibits196: Johnson and Johnson Services Inc. - Key offerings
  • Exhibits197: Johnson and Johnson Services Inc. - Segment focus
  • Exhibits198: SWOT
  • Exhibits199: Merck and Co. Inc. - Overview
  • Exhibits200: Merck and Co. Inc. - Business segments
  • Exhibits201: Merck and Co. Inc. - Key news
  • Exhibits202: Merck and Co. Inc. - Key offerings
  • Exhibits203: Merck and Co. Inc. - Segment focus
  • Exhibits204: SWOT
  • Exhibits205: Moderna Inc. - Overview
  • Exhibits206: Moderna Inc. - Product / Service
  • Exhibits207: Moderna Inc. - Key offerings
  • Exhibits208: SWOT
  • Exhibits209: Pfizer Inc. - Overview
  • Exhibits210: Pfizer Inc. - Product / Service
  • Exhibits211: Pfizer Inc. - Key news
  • Exhibits212: Pfizer Inc. - Key offerings
  • Exhibits213: SWOT
  • Exhibits214: Sanofi SA - Overview
  • Exhibits215: Sanofi SA - Business segments
  • Exhibits216: Sanofi SA - Key news
  • Exhibits217: Sanofi SA - Key offerings
  • Exhibits218: Sanofi SA - Segment focus
  • Exhibits219: SWOT
  • Exhibits220: Serum Institute of India Pvt. Ltd. - Overview
  • Exhibits221: Serum Institute of India Pvt. Ltd. - Product / Service
  • Exhibits222: Serum Institute of India Pvt. Ltd. - Key offerings
  • Exhibits223: SWOT
  • Exhibits224: Shenzhen Kangtai Biological Products Co. Ltd. - Overview
  • Exhibits225: Shenzhen Kangtai Biological Products Co. Ltd. - Product / Service
  • Exhibits226: Shenzhen Kangtai Biological Products Co. Ltd. - Key offerings
  • Exhibits227: SWOT
  • Exhibits228: Valneva SE - Overview
  • Exhibits229: Valneva SE - Business segments
  • Exhibits230: Valneva SE - Key offerings
  • Exhibits231: Valneva SE - Segment focus
  • Exhibits232: SWOT
  • Exhibits233: VBI Vaccines Inc. - Overview
  • Exhibits234: VBI Vaccines Inc. - Product / Service
  • Exhibits235: VBI Vaccines Inc. - Key offerings
  • Exhibits236: SWOT
  • Exhibits237: Zydus Lifesciences Ltd. - Overview
  • Exhibits238: Zydus Lifesciences Ltd. - Business segments
  • Exhibits239: Zydus Lifesciences Ltd. - Key news
  • Exhibits240: Zydus Lifesciences Ltd. - Key offerings
  • Exhibits241: Zydus Lifesciences Ltd. - Segment focus
  • Exhibits242: SWOT
  • Exhibits243: Inclusions checklist
  • Exhibits244: Exclusions checklist
  • Exhibits245: Currency conversion rates for US$
  • Exhibits246: Research methodology
  • Exhibits247: Information sources
  • Exhibits248: Data validation
  • Exhibits249: Validation techniques employed for market sizing
  • Exhibits250: Data synthesis
  • Exhibits251: 360 degree market analysis
  • Exhibits252: List of abbreviations
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!